Amgen Inc.
S&P 500Last update: Mar 25, 2026 at 04:53
About Amgen Inc.
Amgen Inc. is a leading biotechnology company that discovers, develops, manufactures, and delivers human therapeutics worldwide. Its principal products target serious illnesses, including Enbrel for rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for plaque psoriasis, psoriatic arthritis, and Behçet's disease oral ulcers; Prolia for postmenopausal osteoporosis; XGEVA to prevent skeletal-related events; and Repatha to reduce risks of myocardial infarction, stroke, and coronary revascularization. Additional key offerings encompass Nplate for immune thrombocytopenia, KYPROLIS for relapsed or refractory multiple myeloma, Aranesp for anemia, EVENITY for osteoporosis, Vectibix for metastatic colorectal cancer, BLINCYTO for acute lymphoblastic leukemia, TEPEZZA for thyroid eye disease, and KRYSTEXXA for chronic refractory gout. Amgen also markets products like Neulasta, MVASI, AMJEVITA, TEZSPIRE, Parsabiv, Aimovig, LUMAKRAS, EPOGEN, KANJINTI, TAVNEOS, RAVICTI, UPLIZNA, and PROCYSBI. Founded in 1980 and headquartered in Thousand Oaks, California, with approximately 28,000 employees, Amgen plays a pivotal role in the biopharmaceutical sector by addressing unmet needs in oncology, inflammation, cardiovascular disease, bone health, and rare disorders, contributing significantly to global healthcare advancements.
Dividend Overview
Dividend Yield
2.68%
Annual Dividend
$9.80
Frequency
Quarterly
Payout Ratio
66.90%
FCF Payout Ratio
63.26%
Stock Price
$348.43
52-Week Range
$261.43 – $391.29
Dividend Health Score
AMGN's dividend appears safe and well-supported. Strengths include a 66.9% earnings payout ratio & 48.7% cfo payout ratio. Areas of concern: 50.2% net debt / total assets & 640.3 debt-to-equity. The dividend has been growing at a 8.27% 5-year CAGR.
Based on 15 of 15 metrics
Payout & Coverage
SafeBalance Sheet
WarningProfitability
Very SafeDividend Track Record
Very SafeDividend History (2016–2025)
AMGN annual dividend per share and yield history
Earnings & Profitability
AMGN earnings per share and net profit margin
Key Dates
Next Ex-Dividend Date
May 15, 2026
Next Payment Date
June 5, 2026
Dividend Growth
3-Year Dividend CAGR
7.05%
5-Year Dividend CAGR
8.27%
10-Year Dividend CAGR
11.66%
3-Year Total Growth
22.68%
5-Year Total Growth
48.75%
10-Year Total Growth
201.27%
Income Calculator
Similar Dividend Stocks
Frequently Asked Questions
What is AMGN's current dividend yield?
When is AMGN's next dividend payment date?
How much does AMGN pay in dividends per year?
Has AMGN been increasing its dividend?
Is AMGN's dividend safe?
How is AMGN's Dividend Health Score calculated?
Want to understand how we rate dividend safety? Read our full methodology
Track AMGN Dividends with OnlyDividends
What will AMGN actually pay you after taxes? Track every payout, get notified on payment dates, and stop guessing.
This page is not investment advice. The content is for informational purposes only and should not be construed as a recommendation to buy, sell, or hold any security. Always do your own research and consult a qualified financial advisor before making investment decisions.
Financial data, including dividend history, earnings, balance sheet metrics, and the Dividend Health Score, is provided for informational purposes only. Data may be delayed or differ from official filings. Past performance does not guarantee future results. Always verify with official sources before making investment decisions.
Market data provided by Twelve Data.